← Evidence map

ReviewStem cell research & therapy2021

A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.

Ehsan Razeghian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

74 papers cite itlatest 60 shown

2021
…
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34321099